Here are the Form 4 insider transactions from Circle8 Group, Inc. (CIRC) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow CIRC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CIRC filings page.
Circle8 Group Inc. (CIRC) reported automatic sales of common stock by CEO and director Guus Paul Wilhelm Franke: 60,000 shares at an average price of $0.50 per share on September 15, 2026; 579,902 shares at $0.42 on September 21, 2026; and 179,457 shares at $0.38 on October 13, 2026. The footnotes state that the sales were not discretionary transactions by the reporting person. No Rule 10b5-1 plan is reported.
Atlantic International Corp. director David Pfeffer exercised previously granted Restricted Stock Units, converting 161,290 RSUs into the same number of shares of common stock on a one-for-one basis. The RSUs were valued at $2.97 per share based on the February 27, 2026 closing price, and Pfeffer held 162,820 common shares directly after the transaction. No shares were sold in connection with this Form 4; it reflects a compensation-related conversion rather than an open-market trade.
Atlantic International Corp. insider Andrew Bressman reported the grant and vesting of 500,000 restricted stock units (RSUs) on January 5, 2026, which were exercised into 500,000 shares of common stock at a value of $1.33 per share, the closing market price on December 31, 2025. After this transaction, he beneficially owns 7,003,971 shares of Atlantic International common stock directly.
The RSUs were issued under the company’s 2025 Omnibus Equity Incentive Plan pursuant to Rule 16b-3 and were granted under a consulting agreement between the issuer and SAB Management LLC, where Bressman is Manager. The filing states this was not a discretionary transaction by the reporting person, and the RSUs vested in full on the grant date.
Atlantic International Corp. General Counsel Michael Tenore reported equity awards and vesting activity. On January 7, 2026, 1,202,901 shares of common stock vested upon exercise of restricted stock units granted under the company’s 2025 Omnibus Equity Incentive Plan. Of these, 360,870 shares were retained by the company to cover tax liabilities, resulting in a net 842,031 shares issued to Tenore. The shares were valued at $1.33 per share, the closing market price on December 31, 2025. Following this transaction, he directly beneficially owned 1,843,725 common shares.
Separately, on January 5, 2026, Tenore was granted 125,000 incentive stock options at an exercise price of $1.33 per share under the same plan. These options cover 125,000 shares of common stock, become fully exercisable six months from the grant date, and expire on July 5, 2031. The filing characterizes both the restricted stock unit vesting and the option grant as transactions made under the equity incentive plan, rather than discretionary open-market trades.
Atlantic International Corp. Chief Operating Officer Matthew Evelt reported a new grant of incentive stock options on January 5, 2026. He was awarded options covering 100,000 shares of common stock with an exercise price of $1.33 per share and no purchase price at grant. According to the filing, these options will vest six months after the grant date, on July 5, 2026. After this grant, Evelt beneficially owns 1,100,000 derivative securities directly, reflecting his total outstanding stock options in the company.